Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Finding Hope

  • Broadcast in Health
Powerful Patient

Powerful Patient

×  

Follow This Show

If you liked this show, you should follow Powerful Patient.
h:47822
s:7216985
archived

Mike and Joyce speak with Dana Dornsife, President and Founder of an organization called Lazarex that helps people identify and participate in clinical trials that may be appropriate for their condition.

Dana first became involved in cancer patient advocacy when her brother-in-law, Mike Miller, was diagnosed with pancreatic cancer in 2003. Mike had three children, the youngest of whom was only four years old.

Dana and her family searched for options for Mike that would buy the family some time and found a clinical trial treatment. Mike was treated successfully and lived long enough for his youngest daughter to have real memories of him.

Since then, Dana has fought tirelessly for improved options for cancer patients who have been told there is no hope left.

Lazarex Cancer Foundation was formed in 2006 to build a bridge to hope, dignity and life for cancer patients and their families. It provides financial assistance to defray the costs associated with patient participation in FDA clinical trials. Additionally, it helps patients navigate their clinical trial options and provide community education and outreach services.

    - helps patients of all ages and walks of life, with all forms of cancer.
    - helps patients take advantage of medical breakthroughs today, because they may not have a tomorrow.
    - believes that the size of a patient's checkbook should not stand between them and the choices they make or the treatments they need.
    - provides resources to fill the gap that exists between when a patient is told there is no more hope and when they are truly done with their journey in life.

For more information, see <a href="http://www.lazarex.org">http://www.lazarex.org</a>

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled